TAF1-dependent transcriptional dysregulation underlies multiple sclerosis
Ontology highlight
ABSTRACT: Multiple sclerosis (MS) is characterized by neuroinflammation and demyelination of the central nervous system (CNS), leading to disability. Genetic variants that confer MS risk implicate genes with immune function, while severity-related variants are associated with CNS-expressed genes. Current MS immunomodulatory therapies decrease relapse rates, but ultimately fail to slow long-term disease progression, which apparently depends on CNS-intrinsic processes. Although the latter remain unknown, GWAS data suggest that RNA polymerase II (RNAPII) promoter-proximal pausing may contribute to oligodendrocyte pathogenicity. Here we report that the C-terminal region of TAF1, a subunit of the general transcription factor TFIID involved in RNAPII promoter-proximal pausing, is underrepresented in postmortem brain tissue from individuals with MS, a phenomenon attributable to endoproteolysis by extralysosomal cathepsin B. Furthermore, we demonstrate in vivo, in genetically modified mice, that TAF1 C-terminal alteration induces changes in RNAPII promoter-proximal pausing that affect oligodendroglial myelination-related genes and result in a transcriptomic signature overlapping that found in MS brains, including increased expression of proinflammatory genes. This is accompanied by CNS-resident white matter neuroinflammation, robust demyelination and motor disability. We also identify C-terminal TAF1 interactors that cooperate to regulate RNAPII pausing, of which two (GTF2B and GTF2H4) show evidence for genetic association to MS4. Our study reveals that TAF1 alteration found in MS converges with genetic susceptibility in a previously unrecognized transcriptional mechanism related to MS progression, and establish a tractable in vivo model for therapeutic development.
ORGANISM(S): Mus Musculus (mouse)
SUBMITTER: José J. Lucas
PROVIDER: PXD086623 | JPOST Repository | Fri Nov 20 00:00:00 GMT 2026
REPOSITORIES: jPOST
ACCESS DATA